IMM 11.0% 40.5¢ immutep limited

Overnight Market report, page-289

  1. 91 Posts.
    lightbulb Created with Sketch. 179
    The below links might be helpful resources to assist in answering, the first link includes treatments approved since 2020.

    All Breast Cancer Approved Treatments.
    https://www.cancer.gov/about-cancer/treatment/drugs/breast

    2010 - 2020 approvals.
    https://pubmed.ncbi.nlm.nih.gov/34711632/

    IMO
    DYOR
    Good Luck to ALL LTH.

    Ps. If you apply SWOT to the above, namely emerging "Threats" other current clinical trials would also need to be considered. Tough question, on top of the recent FDA advise its apparent the company has to consider an enormous amount of detail in the new trial design. Perhaps why its taking so long to formulate?
    https://www.breastcancertrials.org/bct_nation/browse_trials.seam
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
40.5¢
Change
0.040(11.0%)
Mkt cap ! $588.3M
Open High Low Value Volume
37.0¢ 40.5¢ 36.8¢ $1.822M 4.681M

Buyers (Bids)

No. Vol. Price($)
1 19739 39.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 45420 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.